✦ LIBER ✦

nab-Paclitaxel in combination with biologically targeted agents for early and metastatic breast cancer

✍ Scribed by Megerdichian, Christine; Olimpiadi, Yuliya; Hurvitz, Sara A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly nab (nanopartic

✍ Roy, V.; LaPlant, B. R.; Gross, G. G.; Bane, C. L.; Palmieri, F. M. 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 71 KB

Nanoparticle albumin-bound (nab™)-paclit

✍ Javier Cortes; Cristina Saura 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 741 KB

Comparison of weekly and every-3-week na

✍ M. Aapro; S. Tjulandin; P. Bhar; W. Gradishar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 57 KB

PO62 DIFFERENT PATTERNS OF TREATMENT WIT

✍ Palumbo, Raffaella; Cazzaniga, Marina; Piazza, Elena; Tondini, Carlo; Ferzi, Ant 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

5063 Paclitaxel combined with ifosfamide

✍ Y.W. Moon; J.H. Kim; H.J. Choi; B.W. Park; S.I. Kim; S.H. Park; J.S. Koo; J.Y. C 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

nab-Paclitaxel for first-line treatment

✍ O’Shaughnessy, Joyce; Gradishar, William J.; Bhar, Paul; Iglesias, Jose 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 424 KB